. Author manuscript; available in PMC: 2013 Jul 5.

Published in final edited form as: Cancer. 2011 Jun 20;117(24):5519–5528. doi: 10.1002/cncr.26215

Table 1.

Patient Characteristics

Patient	Age, y	Race	Grade	Stage^a	Histology	Source	CD44%^b
OVA 1	33	C	G3	IIC	OSPC	Ovary	3.13
OVA 2	79	C	G3	IIC	OSPC	Omentum	5.46
OVA 3	37	C	G3	IIIC	OSPC	Ovary	2.46
OVA 4	32	C	G3	IC	Clear cell	Ovary	28.47
OVA 5	64	C	G3	IIIC	OSPC	Ascites	6.62
OVA 1R	33	C	G3	Recurrence	OSPC	Ascites	22.66
OVA 2R	55	C	G3	Recurrence	OSPC	Ascites	14.09
OVA 3R	78	C	G3	Recurrence	OSPC	Ascites	15.14
OVA 4R	69	C	G3	Recurrence	OSPC	Omentum	21.94
OVA 5R	53	C	G3	Recurrence	OSPC	Ascites	6.43

Abbreviations: C, Caucasian; OSPC, ovarian serous papillary carcinoma.

International Federation of Gynecology and Obstetrics operative staging system.

Mean percentage of CD44⁺ cancer stem cells ± standard error = 12.6% ± 2.9%.